| Market Capitalization (Millions $) |
177 |
| Shares
Outstanding (Millions) |
96 |
| Employees |
24 |
| Revenues (TTM) (Millions $) |
7 |
| Net Income (TTM) (Millions $) |
24 |
| Cash Flow (TTM) (Millions $) |
20 |
| Capital Exp. (TTM) (Millions $) |
0 |
Redhill Biopharma Ltd
RedHill Biopharma Ltd. is a specialty biopharmaceutical company focused on the development and commercialization of drugs for the treatment of gastrointestinal diseases, cancer, and infectious diseases. Founded in 2009, the company is headquartered in Tel Aviv, Israel, and has offices in the United States and Europe.
RedHill's portfolio of drugs includes innovative and effective treatments for several conditions. Its lead product, Talicia, is a combination tablet designed to treat Helicobacter pylori (H. pylori) infection, a common cause of peptic ulcers. The company also markets EnteraGam, a medical food for the dietary management of chronic diarrhea and other gastrointestinal disorders. Other pipeline products include RHB-107, a treatment for multiple myeloma, and RHB-204, a potential therapy for pulmonary nontuberculous mycobacteria (NTM) disease.
RedHill has a unique drug development approach that involves repurposing existing drugs for new indications. This approach allows the company to leverage existing safety and efficacy data and expedite the regulatory approval process. RedHill also invests in innovative drug development programs that target unmet medical needs.
The company has a strong financial position, with a cash balance of $38.8 million at the end of 2020. In addition, RedHill has collaborated with several major pharmaceutical companies, including AstraZeneca, Pfizer, and Teva, to develop and commercialize its products.
RedHill is committed to advancing its mission of developing innovative drugs to improve patient outcomes. The company's dedication and focus on improving the lives of patients has led to numerous industry awards and recognitions, including the Frost & Sullivan 2020 North American New Product Innovation Award for Talicia.
Company Address: 21 Ha?arba?a Street Tel Aviv 6473921
Company Phone Number: 3-541-3131 Stock Exchange / Ticker: NASDAQ RDHL
|
41.04% 